Article Details

Intratumoral Injection of mRNA-2752 and Pembrolizumab in High-Risk DCIS

Retrieved on: 2025-02-12 18:07:13

Tags for this article:

Click the tags to see associated articles and topics

Intratumoral Injection of mRNA-2752 and Pembrolizumab in High-Risk DCIS. View article details on hiswai:

Excerpt

... mRNA-2752 (a combination of interleukin [IL]-23, IL-36γ, and OX40L mRNAs) was active in patients with high-risk ductal carcinoma in situ (DCIS).

Article found on: ascopost.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up